ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd (GLMD)

3,05
-0,02
(-0,65%)
Geschlossen 21 Dezember 10:00PM
3,05
0,00
(0,00%)
Nach Börsenschluss: 1:39AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
3,05
Gebot
2,50
Fragen
3,57
Volumen
72.055
2,89 Tagesbereich 3,318
2,56 52-Wochen-Bereich 23,80
Marktkapitalisierung
Handelsende
3,07
Handelsbeginn
3,28
Letzte Trade
10
@
2.97
Letzter Handelszeitpunkt
Finanzvolumen
US$ 222.897
VWAP
3,0934
Durchschnittliches Volumen (3 Mio.)
99.387
Ausgegebene Aktien
643.690
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,28
Gewinn pro Aktie (EPS)
-10,74
Erlöse
-
Nettogewinn
-6,91M

Über Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Tel Aviv, Center, Isr
Gegründet
-
Galmed Pharmaceuticals Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLMD. The last closing price for Galmed Pharmaceuticals was US$3,07. Over the last year, Galmed Pharmaceuticals shares have traded in a share price range of US$ 2,56 to US$ 23,80.

Galmed Pharmaceuticals currently has 643.690 shares in issue. The market capitalisation of Galmed Pharmaceuticals is US$1,98 million. Galmed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.28.

GLMD Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.2810.10830324912.773.392.73693303.0858612CS
40.248.54092526692.813.392.56457852.92447555CS
12-4.01-56.79886685557.067.762.56993873.98583132CS
26-1.012-24.9138355494.06223.82.56146734611.14860222CS
52-1.486-32.76014109354.53623.82.5681423010.57534922CS
156-371.35-99.1853632479374.4392.3822.5637247831.03236436CS
260-970.75-99.6867940029973.81302.752.56292981188.19943175CS

GLMD - Frequently Asked Questions (FAQ)

What is the current Galmed Pharmaceuticals share price?
The current share price of Galmed Pharmaceuticals is US$ 3,05
How many Galmed Pharmaceuticals shares are in issue?
Galmed Pharmaceuticals has 643.690 shares in issue
What is the market cap of Galmed Pharmaceuticals?
The market capitalisation of Galmed Pharmaceuticals is USD 1,98M
What is the 1 year trading range for Galmed Pharmaceuticals share price?
Galmed Pharmaceuticals has traded in the range of US$ 2,56 to US$ 23,80 during the past year
What is the PE ratio of Galmed Pharmaceuticals?
The price to earnings ratio of Galmed Pharmaceuticals is -0,28
What is the reporting currency for Galmed Pharmaceuticals?
Galmed Pharmaceuticals reports financial results in USD
What is the latest annual profit for Galmed Pharmaceuticals?
The latest annual profit of Galmed Pharmaceuticals is USD -6,91M
What is the registered address of Galmed Pharmaceuticals?
The registered address for Galmed Pharmaceuticals is 16 TIOMKIN STREET, TEL AVIV, CENTER, 6578317
What is the Galmed Pharmaceuticals website address?
The website address for Galmed Pharmaceuticals is www.galmedpharma.com
Which industry sector does Galmed Pharmaceuticals operate in?
Galmed Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
120,01M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,64M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,95M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,61k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,4M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock